Total planned funding: $370,596,650
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Namibia | $370,596,650 |
Organizational Types
NGO | $105,133,011 |
Private Contractor | $77,523,979 |
Host Country Government Agency | $53,686,471 |
Own Agency | $48,590,623 |
University | $34,692,118 |
Unknown | $34,551,023 |
Parastatal | $5,797,413 |
Other USG Agency | $4,822,681 |
Implementing Agency | $3,126,607 |
FBO | $1,838,966 |
Multi-lateral Agency | $833,758 |
Program Areas
Treatment | $99,857,091 |
Care | $78,216,007 |
Prevention | $77,390,671 |
Governance and Systems | $58,999,939 |
Management and Operations | $28,969,257 |
Testing | $27,163,685 |
Budget Codes
HTXS: Treatment: Adult Treatment | $81,979,893 |
HVMS: Management and Operations | $28,969,257 |
HKID: Care: Orphans and Vulnerable Children | $27,903,222 |
HVCT: Testing: HIV Testing and Counseling | $27,163,685 |
HBHC: Care: Adult Care and Support | $26,531,165 |
OHSS: Health Systems Strengthening | $26,510,052 |
HVSI: Strategic Information | $24,742,788 |
HVOP: Sexual Prevention: Other Sexual Prevention | $23,759,456 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $17,956,100 |
HVTB: Care: TB/HIV | $16,968,699 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $16,649,256 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $14,511,608 |
PDTX: Treatment: Pediatric Treatment | $10,008,073 |
HTXD: Treatment: ARV Drugs | $7,869,125 |
HLAB: Laboratory Infrastructure | $7,747,099 |
PDCS: Care: Pediatric Care and Support | $6,812,921 |
HMBL: Biomedical Prevention: Blood Safety | $2,660,220 |
HMIN: Biomedical Prevention: Injection Safety | $1,854,031 |
Top Partner Programs
Potentia Namibia:
$42,129,826
Countries/Regions
University of Washington:
$35,155,751
Countries/Regions
Not Available:
$27,661,918
Countries/Regions